Tweaked ‘New Drugs’ Flouted Price Approval Norms In India
Executive Summary
Pharmaceutical firms face more flak in India for allegedly flouting pricing norms – this time more than 200 formulations were allegedly launched in the country without seeking price approvals, though some companies claim they are fully compliant with the norms.